SG11201501540VA - Crystalline compounds - Google Patents

Crystalline compounds

Info

Publication number
SG11201501540VA
SG11201501540VA SG11201501540VA SG11201501540VA SG11201501540VA SG 11201501540V A SG11201501540V A SG 11201501540VA SG 11201501540V A SG11201501540V A SG 11201501540VA SG 11201501540V A SG11201501540V A SG 11201501540VA SG 11201501540V A SG11201501540V A SG 11201501540VA
Authority
SG
Singapore
Prior art keywords
crystalline compounds
crystalline
compounds
Prior art date
Application number
SG11201501540VA
Inventor
Bruno Baillon
Virginie Baulier
Myriam Comte
Matthieu Fugier
Stéphane Kozlovic
Marc-Antoine Perrin
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of SG11201501540VA publication Critical patent/SG11201501540VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
SG11201501540VA 2012-09-13 2013-09-13 Crystalline compounds SG11201501540VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261700618P 2012-09-13 2012-09-13
FR1356284 2013-06-28
PCT/EP2013/069068 WO2014041144A1 (en) 2012-09-13 2013-09-13 Crystalline compounds

Publications (1)

Publication Number Publication Date
SG11201501540VA true SG11201501540VA (en) 2015-03-30

Family

ID=50277664

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201501540VA SG11201501540VA (en) 2012-09-13 2013-09-13 Crystalline compounds

Country Status (16)

Country Link
US (1) US9388143B2 (en)
EP (1) EP2895467A1 (en)
JP (1) JP2015528482A (en)
KR (1) KR20150056565A (en)
CN (1) CN104781241A (en)
AR (1) AR092501A1 (en)
AU (1) AU2013314292A1 (en)
BR (1) BR112015004901A2 (en)
CA (1) CA2884337A1 (en)
IL (1) IL237458A0 (en)
MX (1) MX2015003151A (en)
RU (1) RU2015113277A (en)
SG (1) SG11201501540VA (en)
TW (1) TW201422594A (en)
UY (1) UY35032A (en)
WO (1) WO2014041144A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3008620A1 (en) * 2013-07-22 2015-01-23 Sanofi Sa COMPRESSOR FORMULATION OF A PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR
CN104730028A (en) * 2015-03-12 2015-06-24 浙江华峰氨纶股份有限公司 Near-infrared spectral detection method for residual content of solvent in polyurethane elastic fiber filaments
DE102015012410B4 (en) 2015-09-24 2021-10-07 Dräger Safety AG & Co. KGaA Process for the production of a respiratory protection filter made of rigid activated carbon material and a respiratory protection filter made of rigid activated carbon material
KR20200129705A (en) * 2019-05-09 2020-11-18 보령제약 주식회사 PI3K Inhibitor of Amorphous and Pharmaceutical Composition Comprising the same
KR20200129704A (en) * 2019-05-09 2020-11-18 보령제약 주식회사 Crystal Polymorphism of PI3K Inhibitor and Method for Producing the Same
CN111239125A (en) * 2020-03-06 2020-06-05 中国药科大学 Glucose colorimetric detection method by using platinum disulfide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5270353B2 (en) * 2005-10-07 2013-08-21 エクセリクシス, インク. Phosphatidylinositol 3-kinase inhibitor and method of use thereof
WO2012065057A2 (en) * 2010-11-12 2012-05-18 Exelixis, Inc. Phosphatidylinositol 3-kinase inhibitors and methods of their use
CN107375289A (en) * 2011-11-01 2017-11-24 埃克塞利希斯股份有限公司 For treating the compound as the kinase inhibitor of phosphatidylinositols 3 of lymphoproliferative malignant tumour
FR3008620A1 (en) * 2013-07-22 2015-01-23 Sanofi Sa COMPRESSOR FORMULATION OF A PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR

Also Published As

Publication number Publication date
MX2015003151A (en) 2015-07-14
CA2884337A1 (en) 2014-03-20
KR20150056565A (en) 2015-05-26
AU2013314292A1 (en) 2015-04-02
US9388143B2 (en) 2016-07-12
TW201422594A (en) 2014-06-16
CN104781241A (en) 2015-07-15
EP2895467A1 (en) 2015-07-22
AR092501A1 (en) 2015-04-22
BR112015004901A2 (en) 2017-07-04
RU2015113277A (en) 2016-11-10
US20150183752A1 (en) 2015-07-02
JP2015528482A (en) 2015-09-28
WO2014041144A1 (en) 2014-03-20
UY35032A (en) 2014-04-30
IL237458A0 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
IL268013A (en) Tetrahydropyrazolopyrimidine compounds
HK1245780B (en) Imidazopyrrolidinone compounds
IL237341A0 (en) Pro-neurogenic compounds
GB201209138D0 (en) Compounds
GB201214750D0 (en) Compounds
GB201215357D0 (en) Compounds
EP2887803A4 (en) Pro-neurogenic compounds
HK1206726A1 (en) Imidazotriazinone compounds
GB201204985D0 (en) Compounds
GB201204125D0 (en) Compounds
EP2943500A4 (en) Crystalline 3-o-fucosyllactose
ME02404B (en) Tetrahydropyrrolothiazine compounds
HK1211283A1 (en) Compounds
IL237458A0 (en) Crystalline compounds
GB201209096D0 (en) Compounds
GB201219820D0 (en) Compounds
HK1206356A1 (en) Lpar - substituted cyanopyrazole compounds lpar-
GB201217310D0 (en) Compounds
GB201223429D0 (en) Compounds
GB201220029D0 (en) Compounds
GB201219819D0 (en) Compounds
GB201218799D0 (en) Compounds
GB201218776D0 (en) Compounds
GB201218774D0 (en) Compounds
GB201218758D0 (en) Compounds